During Q4 2018 the big money sentiment decreased to 0.86. That’s change of 0.45, from 2018Q3’s 1.31. 59 investors sold all, 172 reduced holdings as Albemarle Corporation ratio dived. 136 rose stakes while 63 funds bought stakes. Funds hold 96.72 million shares thus 1.41% more from 2018Q3’s 95.38 million shares.
Suntrust Banks holds 34,846 shs. Kistler holds 1,233 shs or 0.04% of its capital. Fdx Advsrs Inc has 0.01% invested in Albemarle Corporation (NYSE:ALB) for 4,031 shs. Thompson Siegel Walmsley Ltd Company owns 5,008 shs. Proshare Limited Liability Corporation owns 19,125 shs. 21,901 were reported by Strategic Services. M&T Bancorp owns 66,561 shs. Cambridge Investment stated it has 0.01% in Albemarle Corporation (NYSE:ALB). Pictet Asset Mgmt Limited reported 0.08% stake. B & T Cap Mngmt Dba Alpha Cap Mngmt reported 0.6% stake. Janney Montgomery Scott Limited Liability Company reported 13,343 shs or 0.01% of all its holdings. Sfe Invest Counsel, a California-based fund reported 8,718 shs. owns 12 shs. Leavell Investment Mngmt owns 38,846 shs for 0.38% of their capital. 5,369 are owned by First Republic Mngmt Inc.

Albemarle Corporation had 3 sales and 0 insider buys since November 26, 2018. This’s net activity of $645,309. 3,343 shs valued at $249,221 were sold by Tozier Scott on Friday, January 4.

Albemarle Corporation (NYSE:ALB) Ratings Coverage

In total 12 analysts cover Albemarle (NYSE:ALB). “Buy” rating has 6, “Sell” are 1, while 5 are “Hold”. (NYSE:ALB) has 50% bullish analysts. 16 are the (NYSE:ALB)’s ratings reports on Mar 23, 2019 according to StockzIntelligence Inc. In Tuesday, December 18 report KeyBanc Capital Markets maintained the stock with “Overweight” rating. On Monday, December 10 HSBC upgraded the shares of ALB in report to “Buy” rating. On Monday, February 25 the stock has “Hold” rating by Deutsche Bank. On Wednesday, November 21 the rating was maintained by Oppenheimer with “Buy”. On Monday, March 18 the firm has “Buy” rating by Jefferies given. On Tuesday, January 15 the stock of Albemarle Corporation (NYSE:ALB) earned “Neutral” rating by Nomura. On Friday, February 22 the stock of Albemarle Corporation (NYSE:ALB) has “Hold” rating given by Nomura. In Tuesday, February 5 report Citigroup downgraded the stock to “Neutral” rating. On Monday, February 25 the stock of Albemarle Corporation (NYSE:ALB) earned “Buy” rating by RBC Capital Markets. The company rating was maintained by Loop Capital Markets on Thursday, February 21. Listed here are Albemarle Corporation (NYSE:ALB) PTs and latest ratings.

22/03/2019 Broker: BidaskScore Rating: Sell Downgrade
18/03/2019 Broker: Jefferies Rating: Buy New Target: $114 Maintain
26/02/2019 Broker: Citigroup Rating: Hold New Target: $92 Maintain
25/02/2019 Broker: RBC Capital Markets Rating: Buy New Target: $113 Maintain
25/02/2019 Broker: Deutsche Bank Rating: Hold New Target: $95 Maintain
22/02/2019 Broker: Nomura Rating: Hold New Target: $89 Maintain
21/02/2019 Broker: Loop Capital Markets Rating: Buy New Target: $119 Maintain
05/02/2019 Broker: Citigroup Old Rating: Buy New Rating: Neutral Old Target: $90 New Target: $81 Downgrade
15/01/2019 Broker: Nomura Old Rating: Buy New Rating: Neutral Old Target: $90 New Target: $85 Downgrade
03/01/2019 Broker: Berenberg Old Rating: Buy New Rating: Hold Downgrade

ALB is touching $82.72 during the last trading session, after decreased 3.26%.Albemarle Corporation has volume of 890,486 shares. Since March 23, 2018 ALB has declined 7.83% and is downtrending. The stock underperformed the S&P 500 by 12.20%.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.The company has $8.75 billion market cap. The firm offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents for applications in lithium batteries, high performance greases, thermoplastic elastomers for car tires, rubber soles and plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications.The P/E ratio is 13.05. It also makes cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for various pyrotechnical applications, including airbag igniters; and performance catalyst solutions, such as polymer catalysts, curatives, organometallics, and electronic materials for polyolefin polymers, packaging, non-packaging, films, injection molding, alpha-olefins, electronic materials, solar cells, polyurethanes, epoxies, and other engineered resins markets.

For more Albemarle Corporation (NYSE:ALB) news announced recently go to: Seekingalpha.com, Streetinsider.com, Fool.com, Fool.com or Investingnews.com. The titles are as follows: “ALB, NAK, HTZ among premarket gainers – Seeking Alpha” announced on February 21, 2019, “Albemarle (ALB) PT Cut At Jefferies, Model Now More Back End Loaded – StreetInsider.com” on March 18, 2019, “3 Top Growth Stocks to Buy in March – The Motley Fool” with a publish date: March 09, 2019, “Albemarle Corporation (ALB) Q4 2018 Earnings Conference Call Transcript – Motley Fool” and the last “VIDEO — Howard Klein: Lithium is a One-way Bet with a Long-term Time Horizon – Investing News Network” with publication date: March 15, 2019.